Pharmacogenomics in Drug Discovery and Development

YAN, Q ed.
Publication
New York, NY : Springer New York : Imprint: Humana Press, 2014.
ISBN
9781493909551 / eISBN:9781493909568
Printed edition: 9781493909551
Edition
2nd ed. 2014.
Physical Description
XIII, 715 p. 44 illus., 32 illus. in color. online resource.
Series
Methods in Molecular Biology Vol 1175
URL
Language
eng
 
 
 
04453nam a22004215i 4500
001
 
 
vtls000095394
003
 
 
VRT
005
 
 
20170623150200.0
007
 
 
cr nn 008mamaa
008
 
 
170620s2014    xxu|    s    |||| 0|eng d
020
$a 9781493909551 / eISBN:9781493909568 $9 978-1-4939-0956-8
024
7
$a 10.1007/978-1-4939-0956-8 $2 doi
039
9
$a 201706231502 $b ella $c 201706200856 $d fatimah $y 201706200834 $z fatimah
100
1
$a YAN, Q ed.
245
1
0
$a Pharmacogenomics in Drug Discovery and Development
250
$a 2nd ed. 2014.
264
1
$a New York, NY : $b Springer New York : $b Imprint: Humana Press, $c 2014.
300
$a XIII, 715 p. 44 illus., 32 illus. in color. $b online resource.
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
347
$a text file $b PDF $2 rda
490
1
$a Methods in Molecular Biology Vol $v 1175
500
$a Springer Protocols
505
0
$a From Pharmacogenomics and Systems Biology to Personalized Care: A Framework of Systems and Dynamical Medicine -- Translational Bioinformatics Approaches for Systems and Dynamical Medicine -- Whole Blood Transcriptomic Analysis to Identify Clinical Biomarkers of Drug Response -- Diagnostic Procedures for Paraffin Embedded Tissues Analysis in Pharmacogenomic Studies -- Approach to Clinical and Genetic Characterization of Statin-Induced Myopathy -- Pharmacogenetics of Membrane Transporters: A Review of Current Approaches -- G Protein-Coupled Receptor Accessory Proteins and Signaling: Pharmacogenomic Insights -- G Protein-Coupled Receptor Mutations and Human Genetic Disease -- Pharmacogenetics of the G Protein-Coupled Receptors -- Pharmacogenomics of Heart Failure -- Pharmacogenomics in the Development and Characterization of Atheroprotective Drugs -- Management of Side-Effects in the Personalized Medicine Era: Chemotherapy Induced Peripheral Neuropathy -- Pharmacogenomics of Alzheimer’s Disease: Novel Therapeutic Strategies for Drug Development -- Pharmacogenetics of Antipsychotic Treatment in Schizophrenia -- Pharmacogenetics of Addiction Therapy -- Pharmacogenetics in Rheumatoid Arthritis -- The Pharmacogenomics of Osteoporotic Fractures -- Pharmacogenomics and Pharmacoepigenomics in Pediatric Medicine -- Pharmacogenomics in Children.
520
$a Covering topics from individual molecules to systemic diseases, from basic concepts to advanced technologies, Pharmacogenomics in Drug Discovery and Development , Second Edition provides a practical, state-of-the-art and integrative view of the application of pharmacogenomics in drug discovery and development. A wide range of theoretical and experimental approaches are introduced to meet the problem-solving objectives for understanding the complexity in health and diseases, from laboratory tests to computational analysis. The development of pharmacogenomics represents the evolution of biomedicine from treating the disease itself to treating the malfunction of an individual person, the “root” of diseases. With the change of focus from disease-centered to human-centric medicine, pharmacogenomics brings hope for the transformation from simple disease treatment to accurate prediction and effective prevention. Written in the successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and easily accessible, Pharmacogenomics in Drug Discovery and Development, Second Edition seeks to serve both professionals and novices with comprehensive resources and a holistic view for the translation of pharmacogenomics into better preventive and personalized medical care.
541
$a EB02786
650
0
$a MEDICINE
650
0
$a PHARMACOLOGY
650
0
$a BIOMEDICINE
650
1
4
$a METHODS AND PROTOCOLS
650
1
4
$a E-BOOKS
776
0
8
$i Printed edition: $z 9781493909551
830
0
$a Methods in Molecular Biology, Methods and Protocols, $x 1064-3745 ; $v 1175
856
4
0
$u http://dx.doi.org/10.1007/978-1-4939-0956-8
856
4
0
$u http://www.springerprotocols.com/doiresolver?genre=book&pid=10.1007/978-1-4939-0956-8
999
$a VIRTUA
999
$a VTLSSORT0070*0080*0200*0240*1000*2450*2500*2640*3000*3360*3370*3380*3470*4900*5050*5200*5410*6500*6501*6502*6503*6504*7760*8300*8560*8561*5000*9992
Subject
MEDICINE
PHARMACOLOGY
BIOMEDICINE
METHODS AND PROTOCOLS
E-BOOKS
Summary
Covering topics from individual molecules to systemic diseases, from basic concepts to advanced technologies, Pharmacogenomics in Drug Discovery and Development , Second Edition provides a practical, state-of-the-art and integrative view of the application of pharmacogenomics in drug discovery and development. A wide range of theoretical and experimental approaches are introduced to meet the problem-solving objectives for understanding the complexity in health and diseases, from laboratory tests to computational analysis. The development of pharmacogenomics represents the evolution of biomedicine from treating the disease itself to treating the malfunction of an individual person, the “root” of diseases. With the change of focus from disease-centered to human-centric medicine, pharmacogenomics brings hope for the transformation from simple disease treatment to accurate prediction and effective prevention. Written in the successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and easily accessible, Pharmacogenomics in Drug Discovery and Development, Second Edition seeks to serve both professionals and novices with comprehensive resources and a holistic view for the translation of pharmacogenomics into better preventive and personalized medical care.
Table of Contents
From Pharmacogenomics and Systems Biology to Personalized Care: A Framework of Systems and Dynamical Medicine -- Translational Bioinformatics Approaches for Systems and Dynamical Medicine -- Whole Blood Transcriptomic Analysis to Identify Clinical Biomarkers of Drug Response -- Diagnostic Procedures for Paraffin Embedded Tissues Analysis in Pharmacogenomic Studies -- Approach to Clinical and Genetic Characterization of Statin-Induced Myopathy -- Pharmacogenetics of Membrane Transporters: A Review of Current Approaches -- G Protein-Coupled Receptor Accessory Proteins and Signaling: Pharmacogenomic Insights -- G Protein-Coupled Receptor Mutations and Human Genetic Disease -- Pharmacogenetics of the G Protein-Coupled Receptors -- Pharmacogenomics of Heart Failure -- Pharmacogenomics in the Development and Characterization of Atheroprotective Drugs -- Management of Side-Effects in the Personalized Medicine Era: Chemotherapy Induced Peripheral Neuropathy -- Pharmacogenomics of Alzheimer’s Disease: Novel Therapeutic Strategies for Drug Development -- Pharmacogenetics of Antipsychotic Treatment in Schizophrenia -- Pharmacogenetics of Addiction Therapy -- Pharmacogenetics in Rheumatoid Arthritis -- The Pharmacogenomics of Osteoporotic Fractures -- Pharmacogenomics and Pharmacoepigenomics in Pediatric Medicine -- Pharmacogenomics in Children.
Notes
Springer Protocols
Methods in Molecular Biology, Methods and Protocols, 1064-3745 ; 1175